Moshkevich Solomon 4

What Happened

• Solomon Moshkevich, President, Clinical Diagnostics at Natera, sold a total of 23,498 shares in two open‑market transactions to satisfy tax withholding related to RSU vesting. On 2026-01-20 he sold 23,205 shares at $234.74 each (reported value $5,447,105) and on 2026-01-21 he sold 293 shares at $235.00 each (reported value $68,855), for a combined proceeds of about $5.52 million. This was a sale (routine tax-withholding sale), not a purchase.

Key Details

• Transaction dates & prices:
  • 2026-01-20: 23,205 shares at $234.74 ($5,447,105)
  • 2026-01-21: 293 shares at $235.00 ($68,855)
• Total shares sold: 23,498; total proceeds ≈ $5,515,960 (~$5.52M)
• Shares owned after transaction: Not specified in the provided filing details.
• Footnotes: Both sales were made to satisfy tax withholding on RSU vesting and were effected pursuant to written instructions intended to satisfy the Rule 10b5-1(c) affirmative-defense conditions. The RSU grants referenced were dated Jan 28, 2022 (F2) and Jan 27, 2023 (F1).
• Filing timeliness: Report filed 2026-01-22 for transactions reported as of 2026-01-20 — appears to be filed within the usual Form 4 reporting window (timely).

Context

• Sales to cover tax withholding on vested RSUs are common and often procedural; they do not necessarily indicate management sentiment about the company’s prospects. The reference to a written instruction intended to meet Rule 10b5-1(c) conditions suggests the sales followed a pre-established process.